The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

Concorde Medical Group PLLC, New York

New York University Medical Center, New York

Salix Site, New York

Columbia University Medical Ctr. Center for Liver Disease & Transplantation, New York

University of Rochester Strong Memorial Hospital, Rochester

Albert Einstien Medical Center, Philadelphia

VCU/MCV Health Systems, Richmond

Carolina Medical Center, Charlotte

Asheville Gastroenterology Associates, PA, Asheville

Gastroenterology Associates, Macon

Tampa General Medical Group, Tampa

Indiana University, Indianapolis

University of Wisconsin Hospital & Clinics, Madison

Mayo Clinic, Rochester

Salix Site, Chicago

St. Louis University, St Louis

Kansas City Research Institute, Kansas City

Salix Site, Jefferson

Delta Research Partners, LLC, Monroe

Integris Nazh Zuhdi Transplant Institute, Oklahoma City

Research Specialists of Texas, Houston

Amcare Research Inc, Houston

Alamo Medical Research, San Antonio

Methodist Hospital, San Antonio

Salix Site, Odessa

University of Colorado Denver, Aurora

South Denver GI, Englewood

University of Utah Hospital, Salt Lake City

Banner Research, Phoenix

Salix Site, Long Beach

UCSD Clinical & Translational Research Institute, La Jolla

Salix Site, San Diego

Southern California Liver Centers, Coronado

Inland Empire Liver Foundation, Rialto

Salix Site, Riverside

UCSF/Fresno - CRMC, Fresno

Salix Site, San Francisco

University of Florida Hepatology, Gainesville

Central Iowa Hospital Corp, Des Moines

The Center for Liver and Biliary Disease, Baltimore

Brigham and Women's Hospital Division of Gastroenterology & Hepatology, Boston

Univ. of Nebraska Medical Center, Omaha

UNC School of Medicine/Division of Gastroenterology and Hepatology, Chapel Hill